Results 151 to 160 of about 82,957 (302)

Internalized Racism Is Associated With Active Suicidal Desire Through Self-Dehumanization and Perceived Burdensomeness. [PDF]

Suicide Life Threat Behav
Quiles JRG, Robison M, Kurtz A, Clausen BK, Schmidt NB.   +4 more
europepmc   +1 more source

Histories in bone: Navigating the ethical landscape of human skeletal collections in South Africa

Anatomical Sciences Education, EarlyView.
Abstract Provenance is at the center of addressing the complicated ethical stewardship of legacy human skeletal collections. Many South African (SA) health science institutions have skeletal collections. While the history of the collections and the demographics of the skeletons have been reported, the provenance of the individuals within the ...
Quenth Chinenere, Beverley Kramer, Brendon K. Billings   +2 more
wiley   +1 more source

Sex, Racial, and Ethnic Diversity of US Musculoskeletal Oncology Fellows, a 10-year Analysis. [PDF]

J Am Acad Orthop Surg Glob Res Rev
Busigó Torres R, Jain C, Valdivia LM, Stern BZ, Hayden BL.   +4 more
europepmc   +1 more source

Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this study is to evaluate the effects of multiple doses of esomeprazole, a strong proton pump inhibitor and acid‐reducing agent, on the pharmacokinetics and safety of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader.
Lana Tran, Naihan Chen, Jennifer A. Winton, Kyle T. Matschke, Smita P. Goodman, Kimberly C. Lee, Yuanyuan Zhang, Weiwei Tan   +7 more
wiley   +1 more source

Quantifying racial inequality in transit access across New York City. [PDF]

PNAS Nexus
Zhang Y, Xu F, Talen E, González MC, Li Y.   +4 more
europepmc   +1 more source

Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Canagliflozin was recently approved in type 2 diabetes mellitus (T2DM) patients ≥10 and <18 years old as a single agent dosed once daily (QD) or in a fixed‐dose combination with metformin dosed twice daily (BID). We characterize canagliflozin pharmacokinetics in paediatric patients with T2DM, compare estimated individual and simulated ...
Nele Goeyvaerts, Per Olsson Gisleskog, Martine Neyens, Juan José Perez Ruixo, Saberi Rana Ali, Iolanda Cirillo, Oliver Ackaert   +6 more
wiley   +1 more source

Racism and racial health inequity: four theories for public health. [PDF]

J Public Health (Oxf)
Parker C, Agbebiyi A, Fuller A, Gupta-Wright M, Husbands S, Licorish J, Marcano S, Pinkerton L, Bowers AP, Parker M.   +9 more
europepmc   +1 more source

Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications

British Journal of Clinical Pharmacology, EarlyView.
Dolutegravir underpins modern first‐ and second‐line HIV treatment regimens; however, interindividual variability in its disposition and tolerability presents challenges for optimal use. This scoping review mapped current evidence on the pharmacogenomics of dolutegravir, focusing on pharmacokinetics and pharmacodynamics, and methodological limitations ...
Ronald Kiguba, Mishael Ssesanga, Munir Pirmohamed   +2 more
wiley   +1 more source

Barriers Individuals From Racial-Ethnic Minority Groups Face in Accessing Eating Disorder Treatment and Proposed Solutions. [PDF]

Psychiatr Serv
Persaud A, Duncan AE, Shields MC.
europepmc   +1 more source

Unequal Access to Evidence-Based Cardiometabolic Therapies: Racial Disparities in SGLT2 Inhibitor and GLP-1 Receptor Agonist Use Among Patients With Type 2 Diabetes and Cardiovascular Disease. [PDF]

Cureus
Obi MF, Ahmad S, Ezechukwu K.
europepmc   +1 more source